Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

[This corrects the article DOI: 10.3389/fonc.2023.

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.

Introduction: Brain metastases are the most common intracranial tumor diagnosed in adults. In patients treated with stereotactic radiosurgery, the incidence of post-treatment radionecrosis appears to be rising, which has been attributed to improved patient survival as well as novel systemic treatments. The impacts of concomitant immunotherapy and the interval between diagnosis and treatment on patient outcomes are unclear.

Passively mode-locked 914-nm Nd:YVO4 laser.

We demonstrate what is to our knowledge the first mode-locked Nd:YVO4 laser operating on the 4F3/2-4I9/2 transition at 914 nm. Using a semiconductor saturable-absorber mirror for passive mode locking, we have obtained 3-ps pulses at a repetition rate of 233.8 MHz.

Compact 10-GHz Nd:GdVO4 laser with 0.5-W average output power and low timing jitter.

We demonstrate a compact, diode-pumped Nd:GdVO4 laser with a repetition rate of 9.66 GHz and 0.5-W average output power.